CNC vs ONCO · P/E 8.4, rev $103.52B vs P/E 0.0, rev $815.4K
Centene Corp (CNC) versus Onconetix Inc (ONCO) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported ONCO revenue for 2025-12-31 was $815.4K. Net income was -$14.0M. Revenue was down 67.7% from 2024-12-31 to 2025-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
Not investment advice. Open the CNC and ONCO stock pages for the full models.
Not investment advice.